| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Hudson Frederick M. is a Director at SUPN. Recent filings cover 0 purchases and 6 sales. Those positions are worth an estimated $3.1M at current prices.
Our model assigns Hudson Frederick M. a below-average insider score of 28/100, based on 3 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -26.1%.
Hudson Frederick M.'s largest disclosed position is in SUPN as Director, worth about $3.1M. The recent filings there lean toward selling, a net 31,561 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | SUPN Supernus Pharmaceuticals, Inc. | Director | Sell | 5,369 | $50.61 | $271,725.09 | -8.2% | -10.6% | - | |
| Aug 14, 2025 | SUPN Supernus Pharmaceuticals, Inc. | Director | Sell | 7,457 | $42.26 | $315,132.82 | -13.9% | +5.8% | +14.5% | |
| Nov 8, 2024 | SUPN Supernus Pharmaceuticals, Inc. | Director | Sell | 8,722 | $36.28 | $316,434.16 | -23.5% | +6.1% | +25.7% | |
| Nov 15, 2023 | SUPN Supernus Pharmaceuticals, Inc. | Director | Sale+OE | 9,093 | $28.50 | $259,150.50 | -21.5% | -5.2% | +26.5% | |
| Jul 13, 2020 | SUPN Supernus Pharmaceuticals, Inc. | Director | Sale+OE | 920 | $24.44 | $22,484.80 | -4.9% | - | - |